Preparation of New Liposomal Daunorubicin and Evaluation of its Anti-colorectal Cancer in HCT116 Cells
Sign Up to like & getrecommendations! Published in 2024 at "Current Bioactive Compounds"
DOI: 10.2174/0115734072312484241010124144
Abstract: Colorectal cancer (CRC) is the third most common cause of cancerrelated deaths worldwide. To develop more effective anti-CRC drugs, this research evaluated the impact of synthesized liposomal daunorubicin on HTC116 colon cancer cell line. Liposomal… read more here.
Keywords: cancer; daunorubicin; ldnr; liposomal daunorubicin ... See more keywords
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
Sign Up to like & getrecommendations! Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2017.187153
Abstract: Survival in children with relapsed/refractory acute myeloid leukemia is unsatisfactory. Treatment consists of one course of fludarabine, cytarabine and liposomal daunorubicin, followed by fludarabine and cytarabine and stem-cell transplantation. Study ITCC 020/I-BFM 2009-02 aimed to… read more here.
Keywords: phase; myeloid leukemia; liposomal daunorubicin; acute myeloid ... See more keywords